Prothena | PRTA - Market Capitalization

Stock Price
9.76
Daily Change
-0.10 -1.01%
Monthly
-7.22%
Yearly
35.93%
Q2 Forecast
9.47

Prothena reported $529.7M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 5.66B 217M May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Exelixis USD 14.34B 3.44B May/2026
Immunic USD 64M 23M Dec/2025
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
MacroGenics USD 102M 4M Dec/2025
Nektar Therapeutics USD 15.62B 14.76B May/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Prothena USD 514M 11M Dec/2025
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026